World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
11799
World Ranking
3346
National Ranking
130

Mirjam H.M. Heemskerk publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mirjam H.M. Heemskerk sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 253 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mirjam H.M. Heemskerk D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mirjam H.M. Heemskerk sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mirjam H.M. Heemskerk is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with substantial contributions to subfields such as Immunology, Oncology, Infectious Diseases, Molecular Biology, and Hematology.

Their research topics focus on various areas of immunological and oncological science, including:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19

Heemskerk has published numerous articles in a variety of scientific journals. Their frequent publication venues include:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • The Journal of Immunology
  • iScience

Recent significant papers include:

  • "Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells," 2022, Cancer Cell
  • "Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19," 2021, Nature Immunology
  • "The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses," 2020, Immunity
  • "Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint," 2021, Nature Communications
  • "Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19," 2022, JAMA Oncology

The scientist often collaborates with a range of coauthors, notably:

  • Renate S. Hagedoorn
  • J.H. Frederik Falkenburg
  • Dennis F.G. Remst
  • Marieke Griffioen
  • Anne K. Wouters

Best Publications

  • Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice

    Willy A Noort;Alwine B Kruisselbrink;Pieternella S in't Anker;Marjolein Kruger

  • Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

    W. A. Erik Marijt;Mirjam H. M. Heemskerk;Freke M. Kloosterboer;Els Goulmy

  • Inhibition of T Cell and Promotion of Natural Killer Cell Development by the Dominant Negative Helix Loop Helix Factor Id3

    Mirjam H.M. Heemskerk;Bianca Blom;Garry Nolan;Alexander P.A. Stegmann

  • Allo-HLA reactivity of virus-specific memory T cells is common.

    Avital L. Amir;Lloyd J. A. D'Orsogna;Dave L. Roelen;Marleen M. van Loenen

  • Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

    Sine Reker Hadrup;Sine Reker Hadrup;Arnold H Bakker;Arnold H Bakker;Chengyi J Shu;Rikke S Andersen

  • Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.

    Mirjam H M Heemskerk;Manja Hoogeboom;Roelof A de Paus;Michel G D Kester

  • Mixed T cell receptor dimers harbor potentially harmful neoreactivity

    Marleen M. van Loenen;Renate de Boer;Avital L. Amir;Renate S. Hagedoorn

  • Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.

    Mirjam H.M. Heemskerk;Manja Hoogeboom;Renate S. Hagedoorn;Michel G.D. Kester

  • Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex

    Mirjam H. M. Heemskerk;Renate S. Hagedoorn;Menno A. W. G. van der Hoorn;Lars T. van der Veken

  • Early stages in the development of human T, natural killer and thymic dendritic cells

    H. Spits;B. Blom;A.-C. Jaleco;K. Weijer

  • Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia.

    Dyantha I. van der Lee;Rogier M. Reijmers;Maria W. Honders;Renate S. Hagedoorn

  • High-throughput identification of antigen-specific TCRs by TCR gene capture

    Carsten Linnemann;Bianca Heemskerk;Pia Kvistborg;Roelof J C Kluin

  • Safety of retroviral gene marking with a truncated NGF receptor.

    C. Bonini;M. Grez;C. Traversari;F. Ciceri

  • Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7

    Arnold H. Bakker;Rieuwert Hoppes;Carsten Linnemann;Mireille Toebes

  • TCR Gene Rearrangements and Expression of the Pre-T Cell Receptor Complex During Human T-Cell Differentiation

    B. Blom;M. C. M. Verschuren;M. C. M. Verschuren;M. H. M. Heemskerk;M. H. M. Heemskerk;A. Q. Bakker;A. Q. Bakker

  • Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy

    Marieke Griffioen;Esther H.M. van Egmond;Michel G.D. Kester;Roel Willemze

  • Designer T cells by T cell receptor replacement.

    Daniel Sommermeyer;Julia Neudorfer;Monika Weinhold;Monika Weinhold;Matthias Leisegang

  • Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile

    Daniëlle Krijgsman;Daniëlle Krijgsman;Natasja L. de Vries;Natasja L. de Vries;Anni Skovbo;Morten N. Andersen

  • Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

    Unknown

  • αβ T-Cell Receptor Engineered γδ T Cells Mediate Effective Antileukemic Reactivity

    Lars T. van der Veken;Renate S. Hagedoorn;Marleen M. van Loenen;Roel Willemze

  • PRAME-Specific Allo-HLA–Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer

    Avital L. Amir;Dirk M. van der Steen;Marleen M. van Loenen;Renate S. Hagedoorn

  • The human leukocyte antigen-presented ligandome of B lymphocytes.

    Chopie Hassan;Michel G.D. Kester;Arnoud H. de Ru;Pleun Hombrink

Frequent Co-Authors

J.H. Frederik Falkenburg
J.H. Frederik Falkenburg Leiden University Medical Center
Peter A. van Veelen
Peter A. van Veelen Leiden University Medical Center
Roel Willemze
Roel Willemze Leiden University Medical Center
Jan W. Drijfhout
Jan W. Drijfhout Leiden University Medical Center
Ton N. M. Schumacher
Ton N. M. Schumacher Antoni van Leeuwenhoek Hospital
Frans H.J. Claas
Frans H.J. Claas Leiden University Medical Center
Sine Reker Hadrup
Sine Reker Hadrup Technical University of Denmark
Hergen Spits
Hergen Spits University of Amsterdam
Jamie Rossjohn
Jamie Rossjohn Monash University
Hans J. Stauss
Hans J. Stauss University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond immunology, pursuing related online degrees can open diverse career paths in healthcare. Many students consider accelerated options that help fast-track their entry into the nursing field. Programs like accelerated FNP programs offer a direct route to becoming Family Nurse Practitioners, combining advanced clinical skills with flexible online learning.

Non-nurses looking to transition into nursing can benefit from online accelerated nursing programs for non nurses. These programs are designed to build foundational skills quickly, providing an efficient way to enter the nursing profession without prior experience.

For those seeking shorter commitments, 12-month accelerated nursing programs offer intensive study options, enabling students to earn their Bachelor of Science in Nursing in just one year. These programs emphasize both theory and clinical practice to prepare students for licensure.

Additionally, individuals interested in practical nursing roles may explore the best easiest LPN programs to get into, which provide accessible paths to becoming Licensed Practical Nurses. These accessible programs are ideal for those seeking quick entry into the workforce with solid foundational training.

Best Scientists Citing Mirjam H.M. Heemskerk

Trending Scientists

Recently Published Articles